Center Laboratories, Inc. (TPEX:4123)
Taiwan · Delayed Price · Currency is TWD 41.10
+0.90 (2.24%)
Sep 3, 2025, 12:00 PM CST
Center Laboratories Market Cap
Center Laboratories has a market cap or net worth of 28.56 billion as of September 2, 2025. Its market cap has decreased by -2.73% in one year.
Market Cap
28.56B
Enterprise Value
33.37B
Revenue
1.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
41.10
Market Cap Chart
Since November 3, 2004, Center Laboratories's market cap has increased from 358.01M to 28.56B, an increase of 7,878.08%. That is a compound annual growth rate of 23.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2025 | 26.72B | -15.43% |
| Dec 31, 2024 | 31.59B | 3.14% |
| Dec 29, 2023 | 30.63B | 8.88% |
| Dec 30, 2022 | 28.13B | -7.93% |
| Dec 30, 2021 | 30.56B | -3.72% |
| Dec 31, 2020 | 31.74B | 30.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 313.31B |
| PharmaEssentia | 165.47B |
| Bora Pharmaceuticals Co., LTD. | 90.22B |
| Lotus Pharmaceutical | 50.89B |
| Oneness Biotech | 33.48B |
| Lumosa Therapeutics | 32.18B |
| Polaris Group | 30.09B |
| Pegavision | 24.84B |